Fatigue Broadly Impacts Patients With RA, Psoriatic Arthritis, Axial Spondyloarthritis

August 08, 2020


A new study in PLOS ONE has highlighted the broad impact fatigue can have on patients with rheumatoid arthritis (RA), psoriatic arthritis, and axial spondyloarthritis.

Specialty Drug Spending After State-Mandated Out-of-Pocket Caps

August 06, 2020


Despite concerns, legislation to cap out-of-pocket payments for specialty drugs has not been shown to shift costs to health plans, thereby increasing insurance premiums, according to a study published in New England Journal of Medicine.

Transitioning Adolescents With Lupus From Pediatric to Adult Care

July 23, 2020


Transferring from pediatric to adult care can result in difficulties for patients with childhood-onset systemic lupus erythematosus.

Evaluating the Presence and Impact of Comorbidities in Rheumatoid Arthritis

July 22, 2020


Comorbidities are common in patients with rheumatoid arthritis, and the presence of comorbidities reduces the chance of remission and is associated with worse functional status and disease activity measures.

Improving RA Outcomes by Promoting Engagement in Physical Activity

July 17, 2020


Promoting engagement in physical activity in early rheumatoid arthritis (RA) can provide small benefits, according to results from a proof of concept study published in Musculoskeletal Care.

Predicting Flares of Rheumatoid Arthritis Disease Activity

July 16, 2020


Research identified a new type of cell that is in the blood during the period before a rheumatoid arthritis flare and may be used to predict a flare in the weeks before one occurs, according to research published in New England Journal of Medicine.

Assessing the Frequency and Impact of Autoimmune Diseases With Hematological Disorders

July 11, 2020


Two abstracts presented at the European Hematology Association's annual meeting evaluated the frequency of myeloid malignancies in patients with autoimmune disease and the impact autoimmune diseases have on patients with sickle cell disease.

Patients With SLE Experienced Delayed Access to Hydroxychloroquine During COVID-19 Pandemic

July 08, 2020


Patients with systemic lupus erythematosus (SLE) may consider hydroxychloroquine essential to their treatment, but after the drug was identified as a potential therapy for coronavirus disease 2019 (COVID-19), patients with SLE experienced reduced access to the treatment, which could increase the risk of SLE flare.

Connection Between Psoriasis and Joint Disease Indicates Early Treatment Can Be Key

July 03, 2020


Researchers identified a protein that can not only worsen skin inflammation but also plays a key role in damaging joints and bones of patients with psoriasis.

Analysis Finds Clinical Insights for Treating AIHA, Non-Hodgkin Lymphoma

February 22, 2020


Though rare, patients with both autoimmune hemolytic anemia (AHIA) and non-Hodgkin lymphoma face stark odds of long-term survival. A new study lends insights into how to best diagnose and treat those patients.